Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy

Critical Care Medicine

Volumn 30, Issue 4, 2002, Pages 900-903

  Nuthall, Gabrielle ^a   Skippen, Peter ^a   Daoust, Christopher ^a   Al Jofan, Fahad ^a   Seear, Michael ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Anticoagulation; Citrate; Continuous renal replacement therapy; Extracorporeal circuit; Regional anticoagulation

Indexed keywords

ANTICOAGULANT AGENT; CITRIC ACID; HEMOSOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULATION; ARTICLE; BLOOD FILTER; BLOOD FLOW VELOCITY; CONTROLLED STUDY; EXTRACORPOREAL CIRCULATION; FLOW RATE; KIDNEY TRANSPLANTATION; MULTIPLE REGRESSION; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; SWINE;

EID: 0036218363     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200204000-00031     Document Type: Article

References (24)

1. Use of pump-assisted hemofiltration in children with acute renal failure
2. Heparin use in continuous renal replacement procedures: The struggle between filter coagulation and patient hemorrhage
3. Matas Lecture: Heparin: Controversies and misconceptions
4. Low molecular weight heparin versus standard heparin. A long term study in hemodialysis and hemofiltration patients
5. Comparison of the use of standard heparin and prostacyclin anticoagulation in spontaneous and pump driven extracorporeal circuits in patients with combined acute renal and hepatic failure
6. Cardiac tamponade secondary to hemorrhagic pericarditis during continuous hemofiltration for renal failure. The role of the anticoagulant
7. The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit
8. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration
9. Maintaining blood flow in the extracorporeal circuit: Hemostasis and anticoagulation
10. Regional citrate anticoagulation in continuous venovenous hemofiltration in critically ill patients with a high risk of bleeding
11. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients
12. Citrate toxicity during massive blood transfusion
13. Effect of anticoagulation on blood membrane interactions during hemodialysis
14. Regional anticoagulation: Hemodialysis with hypertonic trisodium citrate
15. Regional hemodialysis anticoagulation: Hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A
16. Citrate anticoagulation during in vivo simulation of slow hemofiltration
17. Calcium threshold in human plasma clotting kinetics
18. Regional citrate anticoagulation in continuous venovenous hemodiafiltration
19. Citric acid intoxication
20. Ionized hypomagnesemia in patients undergoing orthotopic liver transplantation: A complication of citrate intoxication
21. Cardiovascular depression secondary to ionic hypocalcemia during hepatic transplantation in humans
22. Altered contractile response in neonatal myocardium to citrate-phosphate-dextrose infusion
23. Hemodynamic effects of intravenously administered sodium citrate
24. Changes in serum calcium fractions and citrate concentrations during massive blood transfusions and cardiopulmonary bypass